Short answer · Medically reviewed summary · Last updated: 2026-05-08
Cholangiocarcinoma, a rare cancer of the bile ducts, is primarily coded under ICD-10-CM code C22.1 for intrahepatic bile duct carcinoma and C24.0 for extrahepatic bile duct carcinoma. In the older ICD-9-CM system, these were classified under codes 155.1 (intrahepatic) and 156.1 (extrahepatic), respectively. What are the clinical classifications of Cholangiocarcinoma? Cholangiocarcinoma is categorized by its anatomical location within the biliary tree.
ICD10 code of Cholangiocarcinoma and ICD9 code
ICD-10 and ICD-9 codes for Cholangiocarcinoma, with classification details for clinicians, coders and patients.
Cholangiocarcinoma, a rare cancer of the bile ducts, is primarily coded under ICD-10-CM code C22.1 for intrahepatic bile duct carcinoma and C24.0 for extrahepatic bile duct carcinoma. In the older ICD-9-CM system, these were classified under codes 155.1 (intrahepatic) and 156.1 (extrahepatic), respectively.
What are the clinical classifications of Cholangiocarcinoma?
Cholangiocarcinoma is categorized by its anatomical location within the biliary tree. Because Cholangiocarcinoma is a rare malignancy with complex diagnostic requirements, precise coding is essential for insurance authorization and clinical tracking. Clinicians distinguish between intrahepatic, perihilar (Klatskin tumor), and distal extrahepatic Cholangiocarcinoma to determine appropriate surgical or oncological interventions.
How is Cholangiocarcinoma diagnosed and tracked?
Diagnosis usually involves a combination of imaging (MRI/MRCP or CT), blood tests for tumor markers like CA 19-9, and tissue biopsy. When documenting Cholangiocarcinoma, medical professionals must specify the site to ensure the correct ICD-10 code is applied. Accurate coding supports the Cholangiocarcinoma patient journey by ensuring that specialized treatments, such as biliary stenting or targeted therapies, are properly documented in the electronic health record.
What data is available for Cholangiocarcinoma patients?
While Cholangiocarcinoma is rare, the DiseaseMaps.org community currently supports 4 members who share their lived experiences and management strategies. Tracking these cases helps the medical community better understand the impact of the disease. Key facts regarding diagnosis include:
- ICD-10 C22.1: Intrahepatic bile duct carcinoma.
- ICD-10 C24.0: Extrahepatic bile duct carcinoma.
- ICD-9 155.1: Malignant neoplasm of intrahepatic bile ducts.
- ICD-9 156.1: Malignant neoplasm of extrahepatic bile ducts.
Next steps
- Consult with a hepatobiliary surgeon or an oncologist specializing in gastrointestinal cancers.
- Request a referral for molecular profiling to identify potential targeted therapy options.
- Join the Cholangiocarcinoma community at DiseaseMaps.org to connect with others navigating similar diagnostic and treatment paths.
- Discuss clinical trial eligibility with your care team via resources like ClinicalTrials.gov.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Portal for rare diseases and orphan drugs
- Cholangiocarcinoma Foundation (cholangiocarcinoma.org)
- World Health Organization (WHO) ICD-10 Classification Browser
